A new documentary revisiting the Theranos saga might seem like an odd entry point for a conversation about enterprise technology buying decisions in 2024, but the themes it raises are strikingly current. As MIT Technology Review noted in its coverage of the film You Can See Everything, the renewed interest in Elizabeth Holmes's story isn't really about nostalgia for a decade-old scandal. It's about a question that never stopped being relevant: how do organizations separate genuinely transformative technology from a confident pitch dressed up to look like one?
That question has new urgency today because of the sheer volume of products now marketed as 'intelligent,' 'autonomous,' or 'AI-powered.' The Theranos case was built on the premise that a black-box device could deliver results too complex for outsiders to verify — investors, regulators, and even partner labs were asked to trust the output without fully understanding the process. Swap 'blood diagnostics' for 'AI-driven threat detection' or 'autonomous network optimization,' and the structural risk looks familiar. Many AI and automation vendors today ask buyers to trust outcomes generated by models and pipelines that are, by design, difficult to inspect from the outside.
Why This Matters for IT and Security Teams
For IT decision-makers across the UAE and wider GCC, the practical takeaway isn't cynicism about AI — it's discipline about due diligence. Enterprise buyers are increasingly presented with tools claiming to autonomously detect intrusions, predict failures, or make security decisions faster than human analysts. Those claims may well be accurate. But as the Theranos story illustrates, the gap between a demo environment and real-world performance at scale can be significant, and that gap is easiest to exploit when buyers don't ask for independent validation.
Security and infrastructure leaders should treat vendor claims about AI capabilities the way a careful investor should have treated Theranos: ask for third-party benchmarks, request proof-of-concept testing on your own data and network conditions, and clarify exactly what the system can and cannot explain about its own decisions. Explainability matters especially in security operations, where an analyst eventually has to justify why an alert was escalated, suppressed, or auto-remediated. A system that cannot account for its own output in a way a human can audit is a liability, regardless of how advanced its underlying model is.
A Practical Angle for Regional Buyers
In procurement terms, this means building evaluation criteria that go beyond marketing decks and vendor-supplied case studies. Reference checks with existing customers operating in similar regulatory and threat environments, pilot deployments with clearly defined success metrics, and contractual clarity around data handling and model transparency should all be standard practice — not optional extras reserved for the largest deals. This is particularly relevant for GCC enterprises operating under evolving data protection and critical-infrastructure regulations, where an unverifiable 'black box' solution can create compliance exposure as well as operational risk.
None of this is an argument against adopting AI-enabled networking or cybersecurity tools; the capabilities are real and increasingly necessary. It's an argument for treating bold claims the way any mature buyer should: with curiosity, a request for evidence, and a willingness to walk away if a vendor can't or won't show its work. As the renewed attention to Theranos reminds us, the most expensive mistakes in technology rarely come from moving too slowly — they come from trusting too quickly.
